Clinical Trial Update: A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia [Phase 1, Phase 2]

View source ↗

Summary

This entry reports a first-in-human clinical trial of KK8123 in adults with X-linked hypophosphatemia, a Phase 1/2 study that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Hypophosphatemia

Drugs mentioned

• KK8123

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: X-linked Hypophosphatemia | Phase 1, Phase 2 | Status: RECRUITING